SCHEMBL755996

SCHEMBL755996

COC(C(=O)O)=C(CCC(C)C)c1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESRRB O95718 2/20 0.42
TSHR P16473 1/20 0.42
KMT2A Q03164 1/20 0.41
SMN1; SMN2 Q16637 4/20 0.40
NPC1 O15118 2/20 0.40
RAB9A P51151 2/20 0.40
HTT P42858 1/20 0.40
HPGD P15428 2/20 0.40
P2RX7 Q99572 1/20 0.39
SRC P12931 1/20 0.39
CASR P41180 1/20 0.39
LMNA P02545 2/20 0.38
PKM P14618 1/20 0.38
KDM4E B2RXH2 2/20 0.38
ALDH1A1 P00352 1/20 0.38
POLB P06746 1/20 0.38
CTDSP1 Q9GZU7 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
AKT1 P31749 1/20 0.37
MAPT P10636 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7088150 0.81 HDAC3 (0.40) ESRRBTSHRKMT2ASMN1; SMN2NPC1
SCHEMBL5178120 0.79 PTGS2 (0.57) ALDH1A1
SCHEMBL1356223 0.78 TSHR (0.48) ESRRBTSHRKMT2ASMN1; SMN2HPGD
SCHEMBL8092296 0.78 CES2 (0.53)
SCHEMBL3084634 0.77 CES2 (0.54)
SCHEMBL5147047 0.77 SMN1; SMN2 (0.41) ESRRBTSHRKMT2ASMN1; SMN2HPGD
SCHEMBL7096425 0.77 CES2 (0.54)
SCHEMBL32074 0.77 CES2 (0.54)
SCHEMBL12469582 0.76 L3MBTL1 (0.43) ESRRBTSHRLMNAL3MBTL1MAPT
SCHEMBL3047141 0.75 HDAC2 (0.42) TSHRKMT2ASMN1; SMN2NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 98 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3154510-B1 COMPOSITION FOR PROTECTING KERATIN MATERIALS FROM SUN OREAL (FR) 2022-01-19 EP claimed
EP-3107526-B1 TOPICAL ANHYDROUS FILL FORMULATION FOR ULTRAVIOLET FILTERS SCHERER TECHNOLOGIES LLC R P (US) 2020-07-29 EP claimed
EP-2853255-B1 Method of formulating a personal care product with substantially no whitening effect when applied on wet skin and compositions thereof HallStar Beauty and Personal Care Innovations Company (US) 2018-11-28 EP claimed
EP-3056192-B1 Complete anhydrous sunscreen composition with under water technology FREZYDERM S A (GR) 2018-11-21 EP claimed
EP-3195849-A1 UV BLOCKING FUNCTIONAL COMPOSITE POWDER PREPARED BY DOUBLY COATING INORGANIC POWDER WITH INORGANIC UV BLOCKING AGENT AND ORGANIC UV ABSORBER, AND UV BLOCKING COSMETIC COMPOSITION USING SAME Chemland. Co., Ltd. (KR) 2017-07-26 EP claimed
EP-1594454-B1 FILM FORMING HYDROALCOHOLIC FOAM STIEFEL RES AUSTRALIA PTY LTD (AU) 2016-07-27 EP claimed
US-9211237-B2 Film foaming hydroalcoholic foam STIEFEL RESEARCH AUSTRALIA PTY LTD (AU) 2015-12-15 US claimed
US-20140017176-A1 FILM FOAMING HYDROALCOHOLIC FOAM STIEFEL RESEARCH AUSTRALIA PTY LTD (AU) 2014-01-16 US claimed
EP-1782792-B1 Ultraviolet ray absorbing composite powder IWASE COSFA CO LTD (JP) 2013-01-09 EP claimed
EP-1360146-B1 PROCESS FOR THE PREPARATION OF AQUEOUS SUSPENSIONS OF ANIONIC COLLOIDAL SILICA HAVING A NEUTRAL PH AND APPLICATIONS THEREOF AZ ELECTRONIC MATERIALS USA (US) 2012-06-13 EP claimed
EP-1899015-B1 COMPOSITION WITH TIGHT CAPSULES CONTAINING A SUNSCREEN AGENT DSM IP ASSETS BV (NL) 2012-03-21 EP claimed
US-20060233727-A9 Film foaming hydroalcoholic foam CONNETICS AUSTRALIA PTY LTD. (AU) 2006-10-19 US claimed
US-20060067894-A1 Film foaming hydroalcoholic foam CONNETICS AUSTRALIA PTY LTD. (AU) 2006-03-30 US claimed
EP-1594454-A1 FILM FORMING HYDROALCOHOLIC FOAM Connetics Australia Pty Limited (AU) 2005-11-16 EP claimed
EP-1059911-B1 FORMULATIONS WITH AN ANTI-VIRAL EFFECT MERCK PATENT GMBH (DE) 2005-04-20 EP claimed
WO-2004071479-A1 FILM FOAMING HYDROALCOHOLIC FOAM CONNETICS AUSTRALIA PTY LTD (AU) 2004-08-26 WO claimed
EP-1059911-A1 FORMULATIONS WITH AN ANTI-VIRAL EFFECT MERCK PATENT GmbH (DE) 2000-12-20 EP claimed
WO-1999044578-A1 FORMULATIONS WITH AN ANTI-VIRAL EFFECT MERCK PATENT GMBH (DE) 1999-09-10 WO claimed
EP-0509904-B1 Microencapsulation of sunscreen products, their preparation process, cosmetic and pharmaceutical compositions containing said microcapsules and their applications ROUSSEL UCLAF (FR) 1996-02-28 EP claimed
WO-2025133665-A1 OIL-IN-WATER EMULSION L V M H RECHERCHE (FR) 2025-06-26 WO disclosed
EP-4452208-A1 AQUEOUS EMULSION L V M H RECHERCHE (FR) 2024-10-30 EP disclosed
WO-2023118912-A1 AQUEOUS EMULSION L V M H RECHERCHE (FR) 2023-06-29 WO disclosed
US-20230040911-A1 Oil-In-Water-Type Emulsion Cosmetic L V M H RECHERCHE (FR) 2023-02-09 US disclosed
EP-4076348-A1 OIL-IN-WATER-TYPE EMULSION COSMETIC L V M H RECHERCHE (FR) 2022-10-26 EP disclosed
EP-4037636-A1 ANTI-UV COSMETIC COMPOSITION Coatex (FR) 2022-08-10 EP disclosed
WO-2021151452-A1 OIL-IN-WATER-TYPE EMULSION COSMETIC L V M H RECHERCHE (FR) 2021-08-05 WO disclosed
WO-2021064299-A1 ANTI-UV COSMETIC COMPOSITION COATEX (FR) 2021-04-08 WO disclosed
EP-3197563-B1 COMPOSITION BASED ON A LIPOPHILIC ORGANIC UV-SCREENING AGENT AND A FILLER OREAL (FR) 2019-10-30 EP disclosed
EP-3546025-A2 USE OF OLEOGELS IN UV ABSORBER COMPOSITIONS BASF SE (DE) 2019-10-02 EP disclosed
EP-2775997-B1 COSMETIC AND DERMATOLOGICAL PHOTOPROTECTIVE PREPARATION WITH IMPROVED WATER RESISTANCE BEIERSDORF AG (DE) 2019-08-07 EP disclosed
US-20190117783-A1 COMPOSITIONS HOSLER, JAMES P. 2019-04-25 US disclosed
US-20190038538-A1 RNA COMPLEXES THAT INHIBIT MELANIN PRODUCTION OLIX PHARMACEUTICALS, INC. (KR) 2019-02-07 US disclosed
US-10064801-B2 RNA complexes that inhibit melanin production OLIX PHARMACEUTICALS, INC. (KR) 2018-09-04 US disclosed
EP-2210619-B1 Scar covering with UV protection BEIERSDORF AG (DE) 2017-12-20 EP disclosed
EP-2773201-B1 IMPROVED COMPOSITIONS COMPRISING POVIDONE-IODINE COMPLEX MICRODERMIS CORP (US) 2017-12-06 EP disclosed
EP-3197563-A1 COMPOSITION BASED ON A LIPOPHILIC ORGANIC SCREENING AGENT AND A FILLER L'OREAL (FR) 2017-08-02 EP disclosed
EP-3195849-A1 UV BLOCKING FUNCTIONAL COMPOSITE POWDER PREPARED BY DOUBLY COATING INORGANIC POWDER WITH INORGANIC UV BLOCKING AGENT AND ORGANIC UV ABSORBER, AND UV BLOCKING COSMETIC COMPOSITION USING SAME Chemland. Co., Ltd. (KR) 2017-07-26 EP disclosed
US-20170165153-A1 COMPOSITION BASED ON A LIPOPHILIC ORGANIC SCREENING AGENT AND A FILLER L'OREAL (FR) 2017-06-15 US disclosed
WO-2017017523-A1 RNA COMPLEXES THAT INHIBIT MELANIN PRODUCTION OLIX PHARMACEUTICALS, INC. (KR) 2017-02-02 WO disclosed
US-20170027837-A1 RNA COMPLEXES THAT INHIBIT MELANIN PRODUCTION OLIX PHARMACEUTICALS, INC. (KR) 2017-02-02 US disclosed
EP-1594454-B1 FILM FORMING HYDROALCOHOLIC FOAM STIEFEL RES AUSTRALIA PTY LTD (AU) 2016-07-27 EP disclosed
WO-2016030193-A1 COMPOSITION BASED ON A LIPOPHILIC ORGANIC SCREENING AGENT AND A FILLER L'OREAL (FR) 2016-03-03 WO disclosed
US-9265726-B2 Foamable suspension gel STIEFEL RESEARCH AUSTRALIA PTY LTD (AU) 2016-02-23 US disclosed
WO-2016005693-A1 STATISTICAL CATIONIC COPOLYMERS, METHOD FOR THEIR SYNTHESIS AND THEIR USE FOR INGREDIENT ENCAPSULATION ISP INVESTMENTS INC. (US) 2016-01-14 WO disclosed
WO-2016005689-A1 USE OF AN AMINATED HOMOPOLYMER FOR ENCAPSULATING INGREDIENTS, METHOD OF SYNTHESIZING AN AEMA HOMOPOLYMER AND METHOD OF ENCAPSULATING INGREDIENTS ISP INVESTMENTS INC. (US) 2016-01-14 WO disclosed
US-9211237-B2 Film foaming hydroalcoholic foam STIEFEL RESEARCH AUSTRALIA PTY LTD (AU) 2015-12-15 US disclosed
EP-2206494-B1 Foamable suspension gel STIEFEL RES AUSTRALIA PTY LTD (AU) 2015-12-02 EP disclosed
US-9012418-B2 Topical administration of at least one double-stranded RNA oligonucleotide (dsRNA) L'OREAL (FR) 2015-04-21 US disclosed
EP-2773201-A1 IMPROVED COMPOSITIONS Microdermis Corporation (US) 2014-09-10 EP disclosed
US-20140248220-A1 FOAMABLE SUSPENSION GEL STIEFEL RESEARCH AUSTRALIA PTY LTD (AU) 2014-09-04 US disclosed
US-8758728-B2 Foamable suspension gel STIEFEL RESEARCH AUSTRALIA PTY LTD (AU) 2014-06-24 US disclosed
EP-2688650-A1 FILM-FORMING COMPOSITION CONTAINING A SUN FILTER, AND USE THEREOF FOR THE TREATMENT OF SCARS Laboratoires Urgo (FR) 2014-01-29 EP disclosed
US-20140017176-A1 FILM FOAMING HYDROALCOHOLIC FOAM STIEFEL RESEARCH AUSTRALIA PTY LTD (AU) 2014-01-16 US disclosed
US-20130280309-A1 FOAMABLE SUSPENSION GEL STIEFEL RESEARCH AUSTRALIA PTY LTD. (AU) 2013-10-24 US disclosed
US-8562959-B2 Film foaming hydroalcoholic foam STIEFEL RESEARCH AUSTRALIA PTY LTD (AU) 2013-10-22 US disclosed
US-8475770-B2 Foamable suspension gel STIEFEL RESEARCH AUSTRALIA PTY LTD (AU) 2013-07-02 US disclosed
US-20130121953-A1 COMPOSITIONS MICRODERMIS CORPORATION (US) 2013-05-16 US disclosed
WO-2013066909-A1 IMPROVED COMPOSITIONS MICRODERMIS CORPORATION (US) 2013-05-10 WO disclosed
EP-2209462-B1 Cosmetic product for protecting the skin from environmental influences COTY GERMANY GMBH (DE) 2013-04-10 EP disclosed
WO-2012131237-A1 FILM-FORMING COMPOSITION CONTAINING A SUN FILTER, AND USE THEREOF FOR THE TREATMENT OF SCARS LABORATOIRES URGO (FR) 2012-10-04 WO disclosed
EP-1465587-B1 ANTIPERSPIRANT COMPOSITIONS UNILEVER PLC (GB) 2012-08-01 EP disclosed
US-8158109-B2 Foamable suspension gel STIEFEL RESEARCH AUSTRALIA PTY LTD (AU) 2012-04-17 US disclosed
US-20110318278-A1 FOAMABLE SUSPENSION GEL STIEFEL RESEARCH AUSTRALIA PTY LTD (AU) 2011-12-29 US disclosed
EP-2210619-A2 Scar covering with UV protection Beiersdorf AG (DE) 2010-07-28 EP disclosed
EP-2206494-A1 Foamable suspension gel Stiefel Research Australia Pty Ltd (AU) 2010-07-14 EP disclosed
EP-2181698-A2 Cosmetic formula with siloxane elastomers and particulate material Beiersdorf AG (DE) 2010-05-05 EP disclosed
EP-2181699-A1 Cosmetic formula with siloxane elastomers for improving microbiological stability Beiersdorf AG (DE) 2010-05-05 EP disclosed
EP-2179721-A1 Cosmetic formula with new siloxane elastomers Beiersdorf AG (DE) 2010-04-28 EP disclosed
US-20090117063-A1 Topical administration of at least one double-stranded RNA oligonucleotide (dsRNA) DURANTON ALBERT 2009-05-07 US disclosed
EP-2010133-A2 FOAMABLE SUSPENSION GEL Stiefel Research Australia Pty Ltd (AU) 2009-01-07 EP disclosed
EP-1748753-B1 BENZYLIDENEN-ßDICARBONYL COMPOUNDS AS NOVEL UV-ABSORBERS SYMRISE GMBH & CO KG (DE) 2008-10-01 EP disclosed
EP-1961453-A2 Benzyliden-ß-dicarbonyl compounds as UV-absorbers Symrise GmbH & Co. KG (DE) 2008-08-27 EP disclosed
US-20080131381-A1 METHODS FOR PHOTOSTABILIZING INGREDIENTS WITHIN COSMETICS, PERSONAL CARE AND HOUSEHOLD PRODUCTS AND COMPOSITIONS OBTAINED THEREFROM MERCK PATENT GESELLSCHAFT (DE) 2008-06-05 US disclosed
WO-2008007224-A2 FOAMABLE SUSPENSION GEL STIEFEL RESEARCH AUSTRALIA PTY LTD (US) 2008-01-17 WO disclosed
US-20070237724-A1 Foamable suspension gel STIEFEL RESEARCH AUSTRALIA PTY LTD (AU) 2007-10-11 US disclosed
EP-1778175-A1 ALPHA-BENZOYL-CINNAMIC ACID NITRILE AS NOVEL UV-ABSORBERS Symrise GmbH & Co. KG (DE) 2007-05-02 EP disclosed
EP-1748753-A1 BENZYLIDENEN-ßDICARBONYL COMPOUNDS AS NOVEL UV-ABSORBERS Symrise GmbH & Co. KG (DE) 2007-02-07 EP disclosed
US-20060233727-A9 Film foaming hydroalcoholic foam CONNETICS AUSTRALIA PTY LTD. (AU) 2006-10-19 US disclosed
EP-1642560-A1 Sunscreen and skincare compositions containing DNA-repairing enzymes STADA ARZNEIMITTEL AG (DE) 2006-04-05 EP disclosed
US-20060067894-A1 Film foaming hydroalcoholic foam CONNETICS AUSTRALIA PTY LTD. (AU) 2006-03-30 US disclosed
WO-2006015954-A1 ALPHA-BENZOYL-CINNAMIC ACID NITRILE AS NOVEL UV-ABSORBERS SYMRISE GMBH & CO. KG (DE) 2006-02-16 WO disclosed
WO-2005107692-A1 BENZYLIDENE-β-DICARBONYL COMPOUNDS AS NOVEL UV-ABSORBERS SYMRISE GMBH & CO. KG (DE) 2005-11-17 WO disclosed
EP-1594454-A1 FILM FORMING HYDROALCOHOLIC FOAM Connetics Australia Pty Limited (AU) 2005-11-16 EP disclosed
US-20050222071-A1 Topical administration of at least one double-stranded RNA oligonucleotide (dsRNA) L'OREAL (FR) 2005-10-06 US disclosed
EP-1059911-B1 FORMULATIONS WITH AN ANTI-VIRAL EFFECT MERCK PATENT GMBH (DE) 2005-04-20 EP disclosed
EP-1465587-A1 ANTIPERSPIRANT COMPOSITIONS UNILEVER PLC (GB) 2004-10-13 EP disclosed
EP-1466892-A1 Novel indanylidene compounds Symrise GmbH & Co. KG (DE) 2004-10-13 EP disclosed
WO-2004071479-A1 FILM FOAMING HYDROALCOHOLIC FOAM CONNETICS AUSTRALIA PTY LTD (AU) 2004-08-26 WO disclosed
EP-1341752-B1 NOVEL INDANYLIDENE COMPOUNDS SYMRISE GMBH & CO KG (DE) 2004-08-04 EP disclosed
US-20040057917-A1 Pharmaceutical composition for treatment and /or prevention of a light-dermatosis HANS-DIETER PRENTNER (AT) 2004-03-25 US disclosed
US-6652843-B2 Containing fiber forming nonpolymeric structurant such as n-acyl aminoacid amide and/or cyclodipeptide UNILEVER HOME & PERSONAL CARE USA DIVISION OF CONOPCO, INC. 2003-11-25 US disclosed
WO-2003092643-A1 LIGHT-PROTECTION FORMULATIONS USING ACRYLONITRILE DERIVATIVES SYMRISE GMBH & CO. KG (DE) 2003-11-13 WO disclosed
US-20030180240-A1 Clear solid suspension; molding material UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC. 2003-09-25 US disclosed
EP-1341752-A1 NOVEL INDANYLIDENE COMPOUNDS HAARMANN & REIMER GMBH (DE) 2003-09-10 EP disclosed
WO-2003059308-A1 ANTIPERSPIRANT COMPOSITIONS UNILEVER PLC (GB) 2003-07-24 WO disclosed
WO-2002038537-A1 NOVEL INDANYLIDENE COMPOUNDS HAARMANN & REIMER GMBH (DE) 2002-05-16 WO disclosed
EP-1153600-A2 Sunscreen and skincare compositions containing DNA-repairing enzymes STADA ARZNEIMITTEL AG (DE) 2001-11-14 EP disclosed
US-6265180-B1 STERILE NONTOXIC DISPERSION FOR USE IN TRANSFERRING MATERIALS INTO CELLS MIBELLE AG COSMETICS (CH) 2001-07-24 US disclosed
US-6265180-B1 STERILE NONTOXIC DISPERSION FOR USE IN TRANSFERRING MATERIALS INTO CELLS MIBELLE AG COSMETICS (CH) 2001-07-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230040911-A1 Oil-In-Water-Type Emulsion Cosmetic CUTA, PHOSPHO1, LIPE ESRRB 4363/4885TSHR 2788/4885KMT2A 2397/4885
US-20050222071-A1 Topical administration of at least one double-stranded RNA oligonucleotide (dsRNA) DCLRE1B, POLRMT, ADAR ESRRB 1988/4885TSHR 3322/4885KMT2A 3634/4885
US-20190117783-A1 COMPOSITIONS POLE3, POLR1C, SSTR3 ESRRB 1686/4885TSHR 114/4885KMT2A 2785/4885
US-20080131381-A1 METHODS FOR PHOTOSTABILIZING INGREDIENTS WITHIN COSMETICS, PERSONAL CARE AND HOUSEHOLD PRODUCTS AND COMPOSITIONS OBTAINED THEREFROM TYR, NISCH, PPOX ESRRB 4785/4885TSHR 4214/4885KMT2A 1583/4885
US-20090117063-A1 Topical administration of at least one double-stranded RNA oligonucleotide (dsRNA) DCLRE1B, POLRMT, ADAR ESRRB 1988/4885TSHR 3322/4885KMT2A 3634/4885
US-20030180240-A1 Clear solid suspension; molding material GRIA1, GLG1, GPR27 ESRRB 3921/4885TSHR 2857/4885KMT2A 2587/4885
US-20170165153-A1 COMPOSITION BASED ON A LIPOPHILIC ORGANIC SCREENING AGENT AND A FILLER CUTA, FABP4, KRT18 ESRRB 4140/4885TSHR 3573/4885KMT2A 2734/4885
US-20130121953-A1 COMPOSITIONS POLE3, POLR1C, SSTR3 ESRRB 1686/4885TSHR 114/4885KMT2A 2785/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.